S&P BSE India Manufacturing PB	3.8
S&P BSE India Manufacturing PE	20.8
S&P BSE India Manufacturing DIV	1.8
S&P BSE India Manufacturing EPS	50.3

S&P BSE India Manufacturing News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on S&P BSE India Manufacturing from all sources in a single place.

Vedanta Ltd.

05 Sep 2025, 08:38PM

445.50

2.25%

Vedanta trumps Adani in closely-contested battle to win bid for Jaiprakash Associates

Business Line

Intense bidding war ends with Vedanta outbidding Adani for Jaiprakash Associates, clinching assets worth 12,505 crore

Vedanta Ltd.'s price crossed above 30Day SMA today

Vedanta pips Adani with Rs 17,000 cr bid for Jaiprakash Associates

Business Standard | 05 Sep 2025, 07:32PM 2 more

Hindustan Aeronautics Ltd.

05 Sep 2025, 08:24PM

4404.80

-0.72%

HAL gets 2nd centre fuselage for LCA Tejas Mk1A from VEM Technologies

Business Line

The first fuselage for the LCA Mk1A was delivered by Larsen & Toubro (L&T)

Hindustan Aeronautics Ltd. has gained 28.63% in the last 6 Months

Tata Motors Ltd.

05 Sep 2025, 08:22PM

691.70

0.61%

Tata Motors to cut passenger vehicle prices by up to 1.45 lakh from Sep 22

Business Standard

Tata Motors on Friday said it will cut passenger vehicle prices ranging between Rs 75,000 and Rs 1.45 lakh effective September 22 to pass on the full benefit of GST reduction to customers. The Mumbai-based auto major said that its small car Tiago will see a price drop of Rs 75,000, Tigor Rs 80,000, and Altroz Rs 1.10 lakh. Similarly, the price of compact SUV Punch will come down by Rs 85,000 and that of Nexon by Rs 1.55 lakh. Mid-sized model Curvv would also see a price cut of Rs 65,000, Tata Motors said in a statement. Prices of company's premium SUVs - Harrier and Safari, wll see a price reduction of 1.4 lakh and Rs 1.45 lakh respectively, it added. "In line with the Hon'ble Prime Minister's vision, the Hon'ble Finance Minister's intent and our Customer First philosophy, Tata Motors will fully honour the intent and spirit of this reform by passing on the entire benefit of the reduction in GST to our customers," Tata Motors Passenger Vehicles MD Shailesh Chandra said. The reduct

Geojit BNP Paribas decreased Hold price target of Tata Motors Ltd. to 734.0 on 01 Sep, 2025.

Reliance Industries Ltd.

05 Sep 2025, 07:23PM

1375.00

1.16%

Company Update

Reliance Industries Ltd - 500325 - Update On Institutional Investors'' Meeting

BSE India

This is further to the disclosure dated September 1, 2025 made by the Company. We wish to inform you that the Company executives participated in the Institutional Investors'' Meeting - Goldman Sachs Asia Leaders Conference and no unpublished price sensitive was shared / discussed in the said one-on-one meeting.

pdf

Sun Pharmaceutical Industries Ltd.

05 Sep 2025, 07:22PM

1593.60

0.71%

Pharma market grows 8.7% in August; cardiac and anti-diabetic segments lead

Business Standard

The Indian Pharma Market grew 8.7% in August 2025, with the cardiac, anti-diabetic, and anti-neoplastic segments driving growth. Sun Pharma maintained its leadership position

Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr

Tata Consumer Products Ltd.

05 Sep 2025, 07:19PM

1072.40

0.12%

Company Update

Tata Consumer Products Ltd - 500800 - Communication Sent To Shareholders Holding Shares In Physical Mode …

BSE India

Enclosed

pdf

Tata Steel Ltd.

05 Sep 2025, 06:48PM

167.68

0.52%

Company Update

Tata Steel Ltd - 500470 - Disclosure Under Regulations 30 And 51 Of Securities And Exchange …

BSE India

Disclosure under Regulations 30 and 51 of SEBI Listing Regulations

pdf

Hindustan Aeronautics Ltd.

05 Sep 2025, 06:35PM

4404.80

-0.72%

India's 15-year defence plan includes nuclear-powered carrier, navy jets

Business Standard

India also plans to induct an unspecified number of new-generation twin-engine, deck-based fighters and light combat aircraft, both being developed by state-owned Hindustan Aeronautics Ltd for navy

Hindustan Aeronautic.. has an average target of 5528.33 from 6 brokers.

Cipla Ltd.

05 Sep 2025, 06:00PM

1553.40

-1.55%

Cipla launches Huena, India's first non-antibiotic drug to fight UTI

Business Standard

Drug firm Cipla on Friday said it has introduced a non-antibiotic treatment for patients suffering from recurrent urinary tract infections. The company has launched Methenamine Hippurate under the brand name HUENA. This marks a significant step forward for the company in its fight against anti-microbial resistance as it becomes the first to introduce such treatment in India, the Mumbai-based drugmaker said in a statement. Urinary tract infections (UTIs) are the second most common reason for antibiotic use in India, with infection cases doubling over the last 30 years. Women are more susceptible to UTIs, which account for 15 per cent of overall antibiotic prescriptions. Methenamine Hippurate offers an effective, non-antibiotic alternative for preventing UTIs by targeting bacteria in the bladder and urinary tract. Studies show it is as effective as long-term, low-dose antibiotic therapy for UTI prevention, with lower costs and no risk of antibiotic resistance. "We believe this...